Treatment of infection due to Pneumocystis carinii.
作者信息
Fishman J A
机构信息
Infectious Disease Unit, Massachusetts General Hosptial, Boston, Massachusetts 02114, USA.
出版信息
Antimicrob Agents Chemother. 1998 Jun;42(6):1309-14. doi: 10.1128/AAC.42.6.1309.
Abstract
摘要
相似文献
1
Treatment of infection due to Pneumocystis carinii.卡氏肺孢子菌感染的治疗。
Antimicrob Agents Chemother. 1998 Jun;42(6):1309-14. doi: 10.1128/AAC.42.6.1309.
2
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.获得性免疫缺陷综合征患者中卡氏肺孢子虫肺炎的管理选择及对甲氧苄啶/磺胺甲恶唑不耐受的情况。
South Med J. 1996 Mar;89(3):272-7. doi: 10.1097/00007611-199603000-00003.
3
[Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS].[艾滋病患者卡氏肺孢子虫肺炎治疗的当前替代方案]
Med Clin (Barc). 1994 Oct 15;103(12):473-6.
4
Treatment of Pneumocystis carinii pneumonia in adults with AIDS.艾滋病成年患者卡氏肺孢子虫肺炎的治疗。
Semin Respir Infect. 1997 Jun;12(2):79-97.
5
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.10种具有抗卡氏肺孢子虫活性的药物在动物模型中的相对效价。
J Infect Dis. 1994 Oct;170(4):906-11. doi: 10.1093/infdis/170.4.906.
6
Prevention of infection due to Pneumocystis carinii.预防卡氏肺孢子虫感染。
Antimicrob Agents Chemother. 1998 May;42(5):995-1004. doi: 10.1128/AAC.42.5.995.
7
Pneumocystis carinii pneumonia treatment in people infected with HIV.感染艾滋病毒者的卡氏肺孢子虫肺炎治疗
Clin Evid. 2004 Jun(11):935-50.
8
Treatment and prophylaxis of Pneumocystis carinii pneumonia.卡氏肺孢子虫肺炎的治疗与预防
Semin Respir Infect. 1998 Dec;13(4):296-303.
9
[Therapy and prevention of pneumocystis carinii pneumonia].卡氏肺孢子虫肺炎的治疗与预防
Internist (Berl). 1995 Dec;36(12):1150-5.
10
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.对人类免疫缺陷病毒（HIV）感染患者预防卡氏肺孢子虫肺炎和弓形虫性脑炎治疗方法的荟萃分析。
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):104-14. doi: 10.1097/00042560-199706010-00002.
引用本文的文献
1
pneumonia in thoracic organ transplantation: Current perspectives and updates.胸器官移植中的肺炎：当前观点与进展
JHLT Open. 2025 Aug 7;10:100367. doi: 10.1016/j.jhlto.2025.100367. eCollection 2025 Nov.
2
Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin.探索一座治疗金矿：金基抗风湿药物金诺芬的抗真菌潜力。
Int J Mol Sci. 2025 Aug 16;26(16):7909. doi: 10.3390/ijms26167909.
3
Guidelines for Antibiotics Prescription in Critically Ill Patients.重症患者抗生素处方指南
Indian J Crit Care Med. 2024 Aug;28(Suppl 2):S104-S216. doi: 10.5005/jp-journals-10071-24677. Epub 2024 Aug 10.
4
ISCCM Position Statement on the Management of Invasive Fungal Infections in the Intensive Care Unit.国际重症监护医学学会关于重症监护病房侵袭性真菌感染管理的立场声明。
Indian J Crit Care Med. 2024 Aug;28(Suppl 2):S20-S41. doi: 10.5005/jp-journals-10071-24747. Epub 2024 Aug 10.
5
Dose Dependent Effect of Sulfamethoxazole on Inhibiting K Channel of Mouse Pancreatic β Cell.磺胺甲恶唑对小鼠胰腺β细胞钾通道抑制作用的剂量依赖性效应
Dose Response. 2023 Sep 28;21(3):15593258231203611. doi: 10.1177/15593258231203611. eCollection 2023 Jul-Sep.
6
Indian Antimicrobial Prescription Guidelines in Critically Ill Immunocompromised Patients.印度重症免疫功能低下患者抗菌药物处方指南
Indian J Crit Care Med. 2019 Jan;23(Suppl 1):S64-S96. doi: 10.5005/jp-journals-10071-23102.
7
Development of highly active anti- bisbenzamidines: insight into the influence of selected substituents on the activity.高活性抗双苯甲脒的研发：深入了解所选取代基对活性的影响。
Medchemcomm. 2017 Oct 5;8(10):2003-2011. doi: 10.1039/c7md00445a. eCollection 2017 Oct 1.
8
Pneumonia in Solid-Organ Transplant Recipients.实体器官移植受者的肺炎
J Fungi (Basel). 2015 Sep 28;1(3):293-331. doi: 10.3390/jof1030293.
9
Pneumocystis Pneumonia in Human Immunodeficiency Virus-infected Adults and Adolescents: Current Concepts and Future Directions.人类免疫缺陷病毒感染的成人和青少年中的肺孢子菌肺炎：当前概念与未来方向
Clin Med Insights Circ Respir Pulm Med. 2015 Aug 12;9(Suppl 1):19-28. doi: 10.4137/CCRPM.S23324. eCollection 2015.
10
Probing the relationship between anti-Pneumocystis carinii activity and DNA binding of bisamidines by molecular dynamics simulations.通过分子动力学模拟探究双脒类化合物抗卡氏肺孢子虫活性与DNA结合之间的关系。
Molecules. 2015 Apr 3;20(4):5942-64. doi: 10.3390/molecules20045942.
本文引用的文献
1
Prevention of infection due to Pneumocystis carinii.预防卡氏肺孢子虫感染。
Antimicrob Agents Chemother. 1998 May;42(5):995-1004. doi: 10.1128/AAC.42.5.995.
2
A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia.对接受静脉注射喷他脒治疗卡氏肺孢子虫肺炎的人类免疫缺陷病毒感染患者的药物不良反应及其危险因素进行的5年回顾性研究。
Clin Infect Dis. 1997 May;24(5):854-9. doi: 10.1093/clinids/24.5.854.
3
Neutralization of interferon-gamma exacerbates pneumocystis-driven interstitial pneumonitis after bone marrow transplantation in mice.在小鼠骨髓移植后，干扰素-γ的中和作用会加剧肺孢子菌驱动的间质性肺炎。
J Clin Invest. 1997 Apr 1;99(7):1637-44. doi: 10.1172/JCI119326.
4
Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.克林霉素/伯氨喹作为卡氏肺孢子虫肺炎的预防用药。
Clin Infect Dis. 1996 Oct;23(4):718-22. doi: 10.1093/clinids/23.4.718.
5
Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.卡氏肺孢子虫的多胺含量及对鸟氨酸脱羧酶抑制剂DL-α-二氟甲基鸟氨酸的反应
Antimicrob Agents Chemother. 1996 Apr;40(4):973-8. doi: 10.1128/AAC.40.4.973.
6
Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.磺胺类药物预防卡氏肺孢子虫肺炎的单药疗效。
Antimicrob Agents Chemother. 1996 Apr;40(4):962-5. doi: 10.1128/AAC.40.4.962.
7
Employment of terbinafine against Pneumocystis carinii infection in rat models.特比萘芬在大鼠模型中抗卡氏肺孢子虫感染的应用。
Br J Dermatol. 1996 Jun;134 Suppl 46:30-2; discussion 40. doi: 10.1111/j.1365-2133.1996.tb15657.x.
8
Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus.雾化喷他脒用于预防感染人类免疫缺陷病毒患者卡氏肺孢子虫肺炎的肺内和全身药代动力学
J Clin Pharmacol. 1995 Dec;35(12):1166-73. doi: 10.1002/j.1552-4604.1995.tb04042.x.
9
Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat.大鼠卡氏肺孢子虫肺炎期间表面活性蛋白A水平升高。
Eur Respir J. 1996 Mar;9(3):565-70. doi: 10.1183/09031936.96.09030565.
10
Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.艾滋病患者轻度至中度卡氏肺孢子虫肺炎三种治疗方案的比较。口服甲氧苄啶-磺胺甲恶唑、氨苯砜-甲氧苄啶和克林霉素-伯氨喹的双盲、随机试验。美国国立过敏与传染病研究所艾滋病临床试验组108研究小组。
Ann Intern Med. 1996 May 1;124(9):792-802. doi: 10.7326/0003-4819-124-9-199605010-00003.
Zotero 插件